Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietin
- 1 August 1992
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 124 (2) , 424-427
- https://doi.org/10.1016/0002-8703(92)90608-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Exercise in Hemodialysis Patients after Treatment with Recombinant Human ErythropoietinNephron, 1991
- Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal diseaseThe American Journal of Cardiology, 1989
- Left ventricular hypertrophy in end-stage renal disease on peritoneal dialysisThe American Journal of Cardiology, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Effects of enhanced afterload (methoxamine) and contractile state (dobutamine) on the left ventricular late-systolic wall stress-dimension relationThe American Journal of Cardiology, 1983
- Cardiovascular changes in chronic hemodialysis patientsKidney International, 1983
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978
- Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.Circulation, 1977
- Wall stress and patterns of hypertrophy in the human left ventricle.Journal of Clinical Investigation, 1975
- Hemodynamics of Uremic AnemiaCirculation, 1971